Last update 16 Dec 2025

Caffeine/Isometheptene Mucate/Metamizole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Neosaldina
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication
Pain
Inactive Indication
Brain InjuriesCognitive DysfunctionDementia, Vascular+ [2]
Originator Organization-
Active Organization
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
Inactive Organization
Queen's UniversityQueen's UniversitySymtrend, Inc.Symtrend, Inc.
License Organization-
Drug Highest PhaseApproved
First Approval Date
Brazil (28 Jan 2004),
Pain
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC36H56N8NaO14S
InChIKeyRNWWIQRQNMHIFA-AXNKDMQCSA-N
CAS Registry1801585-49-8

Related

100 Clinical Results associated with Caffeine/Isometheptene Mucate/Metamizole
Login to view more data
100 Translational Medicine associated with Caffeine/Isometheptene Mucate/Metamizole
Login to view more data
100 Patents (Medical) associated with Caffeine/Isometheptene Mucate/Metamizole
Login to view more data
1
Literatures (Medical) associated with Caffeine/Isometheptene Mucate/Metamizole
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]Q4 · BIOLOGY
Bacteriocinogenic Lactococcus lactis subsp: lactis DF04Mi isolated from goat milk: Evaluation of the probiotic potential
Q4 · BIOLOGY
100 Deals associated with Caffeine/Isometheptene Mucate/Metamizole
Login to view more data

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain
Brazil
Takeda Pharmaceutical Co., Ltd.Takeda Pharmaceutical Co., Ltd.
28 Jan 2004
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
UlcerPhase 2
Canada
Queen's UniversityQueen's University
31 Jan 2004
Varicose UlcerPhase 2
Canada
Queen's UniversityQueen's University
31 Jan 2004
Wounds and InjuriesPhase 2
Canada
Queen's UniversityQueen's University
31 Jan 2004
Brain InjuriesPhase 1
United States
Symtrend, Inc.Symtrend, Inc.
-
Cognitive DysfunctionPhase 1
United States
Symtrend, Inc.Symtrend, Inc.
-
Dementia, VascularPhase 1
United States
Symtrend, Inc.Symtrend, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free